Atnaujinkite slapukų nuostatas

El. knyga: Nano Physical Pharmaceutics

Edited by
  • Formatas: 260 pages
  • Išleidimo metai: 28-Nov-2024
  • Leidėjas: Jenny Stanford Publishing
  • Kalba: eng
  • ISBN-13: 9781040117972
  • Formatas: 260 pages
  • Išleidimo metai: 28-Nov-2024
  • Leidėjas: Jenny Stanford Publishing
  • Kalba: eng
  • ISBN-13: 9781040117972

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Nanomedicine is an emerging and rapidly evolving field, which could significantly help in early disease diagnosis, therapeutic improvement, novel therapeutic modality development, and medical expenditure reduction. The challenge remains, however, that the specially designed and carefully synthesized nanomedicines function poorly in animal verification despite great performance in vitro. A deeper understanding of the physicochemical properties of nanomedicine is the key.

This book applies physical theories and models to determine the parameters for controlling the physicochemical properties of nanomedicines, including micelles, liposomes, and inorganic nanoparticles. Qualitative and quantitative relationships are established to provide guidance for nanomedicine design, characterization, and analysis. The text also compiles cutting-edge research in nanomedicine from the interdisciplinary team of the Department of Nanomedicine at Naval Medical University, China, which is currently establishing the characteristic discipline called Nano Physical Pharmaceutics. Edited by Wei Li, a prominent nanotechnology researcher, this book will appeal to anyone involved in nanotechnology, medicine, macromolecular science, biology, chemistry, and especially those with an interest in drug delivery or cancer therapy.



This book applies physical theories and models to determine the parameters for controlling the physicochemical properties of nanomedicines, including micelles, liposomes, and inorganic nanoparticles. Qualitative and quantitative relationships are established to provide guidance for nanomedicine design, characterization, and analysis.

1. The Fundamentals and Powerful Tool for Nano Physical Pharmaceutics
2. Nano Physical Pharmaceutics of Micelle-Based Systems
3. Nano Physical Pharmaceutics of Liposome-Based System
4. Nano Physical Pharmaceutics of Inorganic Nanoparticles
5. Nano Physical Pharmaceutics of Nanogel Delivery System
6. Nano Physical Pharmaceutics of Microsphere Delivery System

Wei Li is professor at Naval Medical University (NMU), China, and director of the Department of Nanomedicine and principal investigator at Shanghai Key Laboratory of Cell Engineering, NMU. He also started a new nanomedical lab at NMU under a special talent program. Dr Li has published over 73 peer-reviewed papers, is chief editor of Nano Physical Pharmaceutics, has created a series of key parameters and qualitative as well as quantitative relationships, and has independently designed five sets of equipment for the translation of nanomedicine, with several products in the trial stage and two formulations successfully translated to application. His research focuses on nano physical pharmaceutics, fine nanocarrier engineering, and nanoimmunotherapy.